NCT06821958View on ClinicalTrials.gov

Amplitude-modulated Radiofrequency Electromagnetic Field Treatment for Advanced Hepatocellular Carcinoma (Immune-RF)

NARecruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

March 1, 2025

Primary Completion Date

June 15, 2026

Study Completion Date

February 28, 2029

Conditions
Hepatocellular Carcinoma (HCC)
Interventions
DEVICE

Radiofrequency electromagnetic field treatment

Radiofrequency electromagnetic field treatment using a carrier frequency of 13.56 MHz

Trial Locations (1)

13353

RECRUITING

Charité University Medicine Berlin, Berlin

All Listed Sponsors
lead

Charite University, Berlin, Germany

OTHER